A Single-dose, Randomized, Open-label, Repeated Cross-over Pharmacokinetic Comparison Study of Two Formulations of Jaktinib Hydrochloride Tablets in Healthy Adult Volunteers Under Fasted Conditions
Latest Information Update: 18 Jan 2024
At a glance
- Drugs Gecaxitinib hydrochloride (Primary)
- Indications Myelofibrosis
- Focus Pharmacokinetics
- Sponsors Suzhou Zelgen Biopharmaceuticals
Most Recent Events
- 09 Jan 2024 Status changed from not yet recruiting to completed.
- 20 Nov 2023 New trial record